HUMAN PAPILLOMAVIRUS 16 E2 REGULATES HOST CELL PATHWAYS IMPORTANT FOR CANCER PROGRESSION AND TREATMENT SENSITIVITY WHICH MAY CONTRIBUTE TO CANCER OUTCOMES